2024-09-03 - Analysis Report
## AMGN Stock Analysis Report

**Company Overview:**  AMGEN (Ticker: AMGN) is a leading global biotechnology company focused on developing, manufacturing, and delivering innovative therapies in various therapeutic areas.

**Performance Analysis:**

**1. Return Analysis:**

* **Cumulative Return:** AMGN's cumulative return is 58.57%, compared to 89.66% for the S&P 500 (VOO).
* **Performance Gap:**  The current performance gap between AMGN and VOO is -31.09%. This means AMGN has underperformed VOO by 31.09%.
* **Relative Performance:** The relative performance gap is 46.06%, indicating that AMGN's current performance is at the 46th percentile compared to its historical performance range.

**2. Recent Price Movement:**

* **Closing Price:** $333.83
* **5-Day Moving Average:** $329.61
* **20-Day Moving Average:** $325.69
* **60-Day Moving Average:** $321.37
* **Analysis:** The price is currently above all three moving averages, suggesting a potential upward trend.

**3. Technical Indicators:**

* **RSI:** 68.97, suggesting the stock is currently in overbought territory.
* **PPO:** 0.17, indicating a positive momentum in the short term.
* **Delta_Previous_Relative_Divergence:** -12.38, showing a short-term decline in relative performance.
* **Expected Return:** 7.55%, representing the estimated maximum 5-year return based on current investment.

**4. Recent Earnings and Outlook:**

| Date      | EPS  | Revenue |
|----------|-----|--------|
| 2024-08-07 | 1.39 | 8.39 B$ |
| 2024-05-03 | -0.21 | 7.45 B$ |
| 2023-10-31 | 3.23 | 6.90 B$ |
| 2023-08-04 | 2.58 | 6.99 B$ |
| 2024-08-07 | 2.58 | 6.99 B$ |

* **Analysis:** The most recent earnings report (2024-08-07) showed a positive EPS of 1.39, beating the analysts' estimates. Revenue also surpassed expectations. This suggests a positive outlook for the company. 

**5. Overall Analysis:**

AMGN has underperformed the S&P 500 in the long term, however, the recent price movement and positive earnings results suggest a potential upward trend in the short term. The stock is currently in overbought territory, but the positive momentum and expected return offer a potential opportunity for growth. It is important to consider the overall market conditions and AMGN's specific industry dynamics before making any investment decisions. 

**Disclaimer:** This analysis is for informational purposes only and does not constitute financial advice. Investing in the stock market carries inherent risks, and it is essential to conduct thorough research and consult with a financial advisor before making any investment decisions. 
